Functional dyspepsia impacts absenteeism and direct and indirect costs.

Clin Gastroenterol Hepatol

Retrospective Analysis, The JeSTARx Group, Newfoundland, New Jersey 07435-1710, USA.

Published: June 2010

Background & Aims: Functional dyspepsia (FD) is a common morbid condition but data are limited on the direct and indirect costs for employees with FD or on its impact on productivity. Few data on absenteeism and no objective information are available. This study aimed to assess the impact of FD on costs and effects on absenteeism and work output (productivity).

Methods: We performed a retrospective analysis of payroll data and adjudicated health insurance medical and prescription claims collected over a 4-year study period (January 1, 2001 to December 31, 2004) from more than 300,000 employees. Data from employees with and without (controls) FD were compared using 2-part regression techniques. Outcome measures included medical (total and by place of service) and prescription costs, absenteeism, and objectively measured productivity output.

Results: Employees with FD (N = 1669) had greater average annual medical and prescription drug costs and indirect costs (owing to sick leave and short- and long-term disability absences) than controls (N = 274,206). Compared with controls, the FD employees incurred costs that were $5138 greater and had greater costs for each place of service (all P < .0001). The employees with FD had an additional 0.83 absence days per year and produced 12% fewer units per hour than controls (both P < .05).

Conclusions: Employees with FD have greater costs at all places of service and lower productivity than employees without FD.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2010.03.003DOI Listing

Publication Analysis

Top Keywords

indirect costs
12
costs
9
functional dyspepsia
8
direct indirect
8
employees
8
medical prescription
8
place service
8
greater costs
8
dyspepsia impacts
4
absenteeism
4

Similar Publications

Dementia Care Research and Psychosocial Factors.

Alzheimers Dement

December 2024

Universidade Federal de São Paulo (UNIFESP), São Paulo, São Paulo/SP, Brazil.

Background: The number of people with dementia (PWD) is increasing worldwide, and especially in low- and middle-income countries (LMIC). Dementia's burden extends beyond mortality and healthcare costs. In LMIC, dementia indirect costs are proportionally higher.

View Article and Find Full Text PDF

Background: Informal care of older adults impacts the lives of millions worldwide. Critically, low- and middle-income countries have the highest proportion of dementia costs related to informal care. Research suggests that older adults' cognitive decline is associated with burden among caregivers, which corroborates the worsening in caregivers' quality of life and mental health.

View Article and Find Full Text PDF

Economic burden of breast cancer in India, 2000-2021 and forecast to 2030.

Sci Rep

January 2025

Faculty of Life and Allied Health Sciences, MS Ramiah University of Applied Sciences (RUAS), MSR Nagar, New BEL Road, Bangalore, 560054, India.

Background Breast cancer represents a significant public health concern in India, accounting for 28% of all cancer diagnoses and imposing a substantial economic burden. This study introduces a novel approach to forecasting the number of breast cancer cases (based on prevalence rates) and estimating the associated economic impact in India using the autoregressive integrated moving average (ARIMA) model. Methods Data on the prevalence of breast cancer in India from 2000 to 2021 were obtained from the Global Burden of Disease (GBD) database.

View Article and Find Full Text PDF

Economic evaluation of newborn screening for congenital cytomegalovirus infection: A systematic review.

Eur J Pediatr

January 2025

Division of Policy Evaluation, Department of Health Policy, Research Institute, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-Ku, Tokyo, 157-8535, Japan.

Purpose: This systematic review analyzes economic evaluations of newborn screening for congenital cytomegalovirus (cCMV) infection to identify key factors influencing cost-effectiveness and differences in methodological approaches.

Methods: Following a pre-registered PROSPERO protocol (CRD42023441587), we conducted a comprehensive literature search across multiple databases on July 4, 2024. The review included both full economic evaluations (cost and outcomes) and partial economic evaluations (cost only).

View Article and Find Full Text PDF

Uncomplicated urinary tract infections (uUTIs) represent a sizable healthcare burden with a substantial negative impact on patients' health-related quality-of-life (HRQoL). However, the HRQoL impact of uUTI from the patient perspective is under-represented in research. A cross-sectional online survey assessed activity impairment and work productivity, HRQoL, costs, and treatment satisfaction of female patients with uUTIs in the US; the current study applies this earlier methodology to Germany to provide a European perspective.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!